21 min listen
AI Draws New Value from Old Medical Technology - Dr. Jacob Donoghue, Co-Founder & CEO of Beacon Biosignals
FromRaise the Line
AI Draws New Value from Old Medical Technology - Dr. Jacob Donoghue, Co-Founder & CEO of Beacon Biosignals
FromRaise the Line
ratings:
Length:
19 minutes
Released:
May 24, 2023
Format:
Podcast episode
Description
In this episode of Raise the Line, we dive into the fascinating story of a very old technology, EEGs, being mined for data using a very new technology, AI, that's changing the way treatments are being developed for disorders of the brain. Joining host Michael Carrese to explain is Dr. Jake Donoghue, co-founder and CEO of Beacon Biosignals, a startup that’s using AI to unlock precision medicine for various neurological, psychiatric and sleep disorders. “We utilize our AI tools to bring quantitative endpoints into clinical trials to see if the drugs are impacting brain activity,” Donoghue explains. AI’s ability to quickly recognize subtle changes in electrical activity that might otherwise go unnoticed can accelerate the trial process and hopefully, approval of new therapies. Donoghue is also interested in the area of sleep medicine because of its connection to a wide variety of issues including depression, PTSD, Parkinson’s and Alzheimer’s disease. “We think there's a lot of opportunity to bring quantitative insights to this fundamental state that all humans go through and map some of these really robust features of brain activity to increase understanding of disease and health.”Mentioned in this episode: https://beacon.bio/
Released:
May 24, 2023
Format:
Podcast episode
Titles in the series (100)
Dr. Abdirahman Mahamud - WHO Incident Manager, Western Pacific Region: Dr. Abdirahman Mahamud of the World Health Organization was among the first to see reports out of China last December about a mysterious pneumonia-like illness that we all now know as COVID-19. He tells host Dr. Rishi Desai that preparedness, widespread testing, and aggressive action to deal with those infected explains why many countries in Asia have fared better than parts of Europe and the U.S. by Raise the Line